Pancreatic Cancer Research

ResearcherErasmus MCNo recent work listed

Stephanie Booy

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5061955331. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 4

  1. Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer. First author DOI 10.1186/s12885-020-07420-0↗
  2. Potentials of interferon therapy in the treatment of pancreatic cancer. Co-author DOI 10.1089/jir.2014.0157↗
  3. IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells. Co-author PMID 26269762↗
  4. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells. Co-author DOI 10.1111/jcmm.12200↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leo J. Hofland · 4 shared papers, 2014–2020 · strength 0.32
  2. Casper H.J. van Eijck · 4 shared papers, 2014–2020 · strength 0.32
  3. Amber Blaauboer · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.